Encompass Health Corp (EHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q3 '21: 4.7B Q4 '21: 4.6B Q1 '22: 4.4B Q2 '22: 4.2B Q3 '22: 4.3B Q4 '22: 4.3B Q1 '23: 4.4B Q2 '23: 4.6B Q3 '23: 4.7B Q4 '23: 4.8B Q1 '24: 5B Q2 '24: 5.1B Q3 '24: 5.2B Q4 '24: 5.4B Q1 '25: 5.5B Q2 '25: 5.7B Q3 '25: 5.8B Q4 '25: 5.9B Q1 '26: 6.1B Q2 '26: 6.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 250M 500M 750M Q1 '18: 581.2M Q2 '18: 597.2M Q3 '18: 606.5M Q4 '18: 555.2M Q1 '19: 572.3M Q2 '19: 567.6M Q3 '19: 564.3M Q4 '19: 612.1M Q1 '20: 604.3M Q2 '20: 536.9M Q3 '20: 536.8M Q4 '20: 563.9M Q1 '21: 547.6M Q2 '21: 609.2M Q3 '21: 599.5M Q4 '21: 559.6M Q1 '22: 548.1M Q2 '22: 529.9M Q3 '22: 516M Q4 '22: 539.5M Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Net Income TTM

0 250M 500M 750M Q3 '21: 406.6M Q4 '21: 412.2M Q1 '22: 392.4M Q2 '22: 327.8M Q3 '22: 273.2M Q4 '22: 271M Q1 '23: 271.2M Q2 '23: 313.9M Q3 '23: 353.8M Q4 '23: 352M Q1 '24: 376.8M Q2 '24: 399.5M Q3 '24: 422.4M Q4 '24: 455.7M Q1 '25: 494.7M Q2 '25: 522.7M Q3 '25: 541M Q4 '25: 566.2M Q1 '26: 609.2M Q2 '26: 621M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 500M 1B 1.5B Q3 '21: 871.7M Q4 '21: 715.8M Q1 '22: 776.2M Q2 '22: 764.9M Q3 '22: 657.4M Q4 '22: 705.8M Q1 '23: 714.8M Q2 '23: 676.9M Q3 '23: 822M Q4 '23: 850.8M Q1 '24: 861.7M Q2 '24: 872.4M Q3 '24: 925M Q4 '24: 1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 200M 400M 600M Q3 '21: 402.8M Q4 '21: 191.2M Q1 '22: 237.5M Q2 '22: 227.4M Q3 '22: 90.2M Q4 '22: 141M Q1 '23: 166.3M Q2 '23: 123.9M Q3 '23: 271.6M Q4 '23: 278.6M Q1 '24: 246.7M Q2 '24: 217.7M Q3 '24: 269.5M Q4 '24: 360.3M Q1 '25: 386.4M Q2 '25: 439.2M Q3 '25: 402.6M Q4 '25: 439.2M Q1 '26: 464.4M Q2 '26: 413.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '20: 99.6M Q2 '20: 99.9M Q3 '20: 99.9M Q1 '21: 100.2M Q2 '21: 100.2M Q3 '21: 100.2M Q1 '22: 100.2M Q2 '22: 100.3M Q3 '22: 100.5M Q1 '23: 100.9M Q2 '23: 101.1M Q3 '23: 101.4M Q1 '24: 102.2M Q2 '24: 102M Q3 '24: 102.1M Q1 '25: 102.1M Q2 '25: 102.3M Q3 '25: 102.3M Q1 '26: 100.6M Q2 '26: 100M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '21: 4.06 Q4 '21: 4.11 Q1 '22: 3.91 Q2 '22: 3.27 Q3 '22: 2.72 Q4 '22: 2.70 Q1 '23: 2.70 Q2 '23: 3.11 Q3 '23: 3.50 Q4 '23: 3.46 Q1 '24: 3.69 Q2 '24: 3.91 Q3 '24: 4.13 Q4 '24: 4.46 Q1 '25: 4.84 Q2 '25: 5.11 Q3 '25: 5.29 Q4 '25: 5.54 Q1 '26: 5.99 Q2 '26: 6.14 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.